Statistics from Altmetric.com
Randomised controlled trial (RCT).
Single blind (assessors blinded).
Follow up period:
Fourteen weeks (treatment period only).
Eighteen primary practices and 23 psychiatric practices in Maryland, USA: enrolment 2001 to 2004.
235 outpatients with a primary diagnosis of DSM-IV non-psychotic major depressive disorder on entry to the STAR*D study, who did not achieve an adequate response (Quick Inventory of Depressive Symptomatology (QIDS-SR16) score ⩽5) or could not tolerate two previous drug regimens delivered in the first two phases of this RCT. Exclusions: primary diagnosis of obsessive compulsive or eating disorders; bipolar or psychotic disorders; conditions contraindicating the use of antidepressive medication; substance abuse needing hospitalisation for detoxification; prior non-response to antidepressive medication; pregnancy, or breastfeeding.
Mirtazapine (15 mg/day titrated up to …
For correspondence: Dr M Fava, Depression Clinical and Research Program, Massachusetts General Hospital, Bulfinch 351, 55 Fruit Street, Boston, MA 02114, USA;
Source of funding: National Institute of Mental Health.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.